Heal
-
DATABASE (312)
-
ARTICLES (3)
Zhenzhen Sun is a veteran investor who has worked in prestigious firms like Morgan Stanley and JP Morgan. After leaving JP Morgan in 2009, she worked for Chinese real estate developer LL Land. She left in 2013 to join PreAngel Partners, an angel investment fund. She recently joined Proxima Ventures, a China-based VC that invests in healthcare technology.
Zhenzhen Sun is a veteran investor who has worked in prestigious firms like Morgan Stanley and JP Morgan. After leaving JP Morgan in 2009, she worked for Chinese real estate developer LL Land. She left in 2013 to join PreAngel Partners, an angel investment fund. She recently joined Proxima Ventures, a China-based VC that invests in healthcare technology.
Founded in 2014, River VC focuses on early-stage investment in startups in the internet, consumer, smart hardware and big health sectors.
Founded in 2014, River VC focuses on early-stage investment in startups in the internet, consumer, smart hardware and big health sectors.
Founded in 2015 by venture capitalists from renowned Chinese investment firms including Morningside, Qiming and Ceyuan, Panda Capital focuses on early-stage investment in the internet sectors of real estate, automobile, finance, corporate services, logistics and healthcare.
Founded in 2015 by venture capitalists from renowned Chinese investment firms including Morningside, Qiming and Ceyuan, Panda Capital focuses on early-stage investment in the internet sectors of real estate, automobile, finance, corporate services, logistics and healthcare.
Aavishkaar (‘invention’ in Hindi) was founded in 2001 as an early stage investor to help build sustainable enterprises in India’s underserved regions. Its VC portfolio, valued at over US$ 155 million, covers key industry sectors including sanitation, healthcare, agriculture and technology. Its Aavishkaar Frontier Fund was created in 2015 to invest in South and Southeast Asian countries like Indonesia, Pakistan and Bangladesh.
Aavishkaar (‘invention’ in Hindi) was founded in 2001 as an early stage investor to help build sustainable enterprises in India’s underserved regions. Its VC portfolio, valued at over US$ 155 million, covers key industry sectors including sanitation, healthcare, agriculture and technology. Its Aavishkaar Frontier Fund was created in 2015 to invest in South and Southeast Asian countries like Indonesia, Pakistan and Bangladesh.
Grupara Ventures focuses on helping startups in the healthcare, retail, foodtech, fintech, biotech and design sectors to transform into global brands. It also provides business and networking support to the startups, including mentoring, office space and access to other investors and potential customers. Grupara has also co-invested and worked with angel investors, such as Mari Elka Pangetsu, Andy Zain, Bunga Citra Lestari, Ashraf Sinclair and Justin Kan.
Grupara Ventures focuses on helping startups in the healthcare, retail, foodtech, fintech, biotech and design sectors to transform into global brands. It also provides business and networking support to the startups, including mentoring, office space and access to other investors and potential customers. Grupara has also co-invested and worked with angel investors, such as Mari Elka Pangetsu, Andy Zain, Bunga Citra Lestari, Ashraf Sinclair and Justin Kan.
Founded in 2007 under the Chinese Fortune 500 company DunAn Group, the investment group manages total fund of RMB 6 billion today, with successful investment in 77 Chinese startups across multiple sectors including healthcare, advanced manufacturing, energy & cleantech, etc. It was nominated for “Top 10 Zhengjiang Investment Group” for seven years in a row and was awarded for “Chinese VC of Best Potential” in 2016 – 2017 by thecapital.com.cn.
Founded in 2007 under the Chinese Fortune 500 company DunAn Group, the investment group manages total fund of RMB 6 billion today, with successful investment in 77 Chinese startups across multiple sectors including healthcare, advanced manufacturing, energy & cleantech, etc. It was nominated for “Top 10 Zhengjiang Investment Group” for seven years in a row and was awarded for “Chinese VC of Best Potential” in 2016 – 2017 by thecapital.com.cn.
Being the first investment group in Zhejiang province to list on the NEEQ market, ZSVC has over 30 funds under its management today, amounting to nearly RMB 40 billion. Founded in 2007, it is the major investor for more than 130 Chinese startups across healthcare, media & entertainment, logistic and advanced manufacturing sectors, with more than 30 successful exits. Headquartered in Hangzhou, it has taken its widely acclaimed “Zhejiang Entrepreneur Experience” to a broader world with subsidiaries in Beijing, Shanghai, Shenzhen, Shenyang and the Silicon Valley.
Being the first investment group in Zhejiang province to list on the NEEQ market, ZSVC has over 30 funds under its management today, amounting to nearly RMB 40 billion. Founded in 2007, it is the major investor for more than 130 Chinese startups across healthcare, media & entertainment, logistic and advanced manufacturing sectors, with more than 30 successful exits. Headquartered in Hangzhou, it has taken its widely acclaimed “Zhejiang Entrepreneur Experience” to a broader world with subsidiaries in Beijing, Shanghai, Shenzhen, Shenyang and the Silicon Valley.
Founded in Shenzhen in 2013, HNF focuses on industries such as mobile internet, entertainment, healthcare and education. It was named one of China’s New Investment Organization’s Top 20 companies for 2017.
Founded in Shenzhen in 2013, HNF focuses on industries such as mobile internet, entertainment, healthcare and education. It was named one of China’s New Investment Organization’s Top 20 companies for 2017.
Founded in 2008 in Shanghai, Stone Capital managed assets over RMB 10 billion in 2017. It focuses on high-growth private enterprises and state-owned companies with special resources in industries such as new material, new energy, high-tech, IT, environmental protection and healthcare.
Founded in 2008 in Shanghai, Stone Capital managed assets over RMB 10 billion in 2017. It focuses on high-growth private enterprises and state-owned companies with special resources in industries such as new material, new energy, high-tech, IT, environmental protection and healthcare.
Yonghua is a specialized investment company under Yongjin Group. With more than 20 years investment experience, it has invested in more than 100 companies, more than 50 of which are listed. Yonghua focuses on the most competitive companies in industries such as finance, e-commerce, education, healthcare, corporation service, new material and artificial intelligence.
Yonghua is a specialized investment company under Yongjin Group. With more than 20 years investment experience, it has invested in more than 100 companies, more than 50 of which are listed. Yonghua focuses on the most competitive companies in industries such as finance, e-commerce, education, healthcare, corporation service, new material and artificial intelligence.
Founded in 2017, Oceanpine Capital focuses on investment opportunities in the TMT, consumption upgrade, advanced manufacturing, and healthcare sectors. Oceanpine Capital mainly invest in private companies with rapid growth, but also look at some opportunities in public companies. HQ in Hong Kong with offices in Beijing and San Francisco.
Founded in 2017, Oceanpine Capital focuses on investment opportunities in the TMT, consumption upgrade, advanced manufacturing, and healthcare sectors. Oceanpine Capital mainly invest in private companies with rapid growth, but also look at some opportunities in public companies. HQ in Hong Kong with offices in Beijing and San Francisco.
Orient Hontai Capital is a subsidiary of Shanghai Orient Securities Capital. HQ is in Beijing.Founded in 2014, it has invested in many companies both in and outside China and mainly focuses on TMT and healthcare areas. Cases closed includes: 1. Invest Shanda games, $430MM, 23% shares, Sep. 2014;2. Acquire CMGE and delist it from Nasdaq, $365MM, 48% shares, July 2015;3. Acquire FunPlus game business, $288MM, 32% shares, Sep. 2015;
Orient Hontai Capital is a subsidiary of Shanghai Orient Securities Capital. HQ is in Beijing.Founded in 2014, it has invested in many companies both in and outside China and mainly focuses on TMT and healthcare areas. Cases closed includes: 1. Invest Shanda games, $430MM, 23% shares, Sep. 2014;2. Acquire CMGE and delist it from Nasdaq, $365MM, 48% shares, July 2015;3. Acquire FunPlus game business, $288MM, 32% shares, Sep. 2015;
Established in July 2009, GP Capital was co-funded by Shanghai International Group, Jiangsu Shagang Group, Huatai Securities and Hengdian Group. It specializes in establishing and managing industrial investment funds and private equity funds. GP Capital manages the RMB 20 billion Shanghai Financial Development Investment Fund. The Fund was sponsored by the Shanghai Municipal People’s Government with approval from the State Council and National Development and Reform Commission. Half of GP Capital's investment has gone to financial firms. It also invests in sectors such as consumer products, healthcare, new energy, culture, etc.
Established in July 2009, GP Capital was co-funded by Shanghai International Group, Jiangsu Shagang Group, Huatai Securities and Hengdian Group. It specializes in establishing and managing industrial investment funds and private equity funds. GP Capital manages the RMB 20 billion Shanghai Financial Development Investment Fund. The Fund was sponsored by the Shanghai Municipal People’s Government with approval from the State Council and National Development and Reform Commission. Half of GP Capital's investment has gone to financial firms. It also invests in sectors such as consumer products, healthcare, new energy, culture, etc.
Headquartered in Zhengzhou, China Reform TUS Fund is China's first capital management fund. Jointly backed by state-level venture capital funds, top Chinese universities and the provincial government, it invests primarily in new energy, healthcare and information technology.
Headquartered in Zhengzhou, China Reform TUS Fund is China's first capital management fund. Jointly backed by state-level venture capital funds, top Chinese universities and the provincial government, it invests primarily in new energy, healthcare and information technology.
iFLYTEK is a Chinese software company that specializes in speech technology such as speech synthesis and speech recognition. Established in 1999, iFLYTEK was listed on the Shenzhen Stock Exchange in 2008. With products like iFLYTEK Voice Input and iFLYTEK ViaFly, it has cornered more than 70% of the Chinese speech technology market. iFLYTEK has made investments in over 60 AI companies in the education, healthcare, loT, connected car and robotics sectors, where its products can be widely applied.
iFLYTEK is a Chinese software company that specializes in speech technology such as speech synthesis and speech recognition. Established in 1999, iFLYTEK was listed on the Shenzhen Stock Exchange in 2008. With products like iFLYTEK Voice Input and iFLYTEK ViaFly, it has cornered more than 70% of the Chinese speech technology market. iFLYTEK has made investments in over 60 AI companies in the education, healthcare, loT, connected car and robotics sectors, where its products can be widely applied.
Neurafarm: Putting an AI plant doctor in farmers' hands
This startup is riding on Indonesia’s urban farming trend with its planting kit and an AI-powered app that identifies plant diseases from photos of unhealthy leaves
HypeLabs wins bumper US$3m seed funding to democratize connectivity
HypeLab's P2P mesh networking technology enables everyone to communicate within their own networks without needing internet, in cities, remote villages and even in disaster zones
Knokcare: Telemedicine app connects you to doctors in 30 minutes
Seeking funding of over €1m, Portugal’s digital healthcare pioneer is expanding its SaaS to tap new markets in Europe, Africa and Latin America
Sorry, we couldn’t find any matches for “Heal”.
POPULAR DATABASE
